Selected research
Industry Research
Oral Nutraceutical Industry Research Report 2026
Market perspective
The global Oral Nutraceutical market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Oral Nutraceutical market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Oral Nutraceutical market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Oral Nutraceutical market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Oral Nutraceutical include DSM, Barilla Group, Freedom Food Group Limited, Glanbia, Hero Group, Kerry Group, Nature’s Bounty, Raisio Group and Archer Daniels Midland, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Oral Nutraceutical market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Oral Nutraceutical.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Oral Nutraceutical Market by Company
DSM
Barilla Group
Freedom Food Group Limited
Glanbia
Hero Group
Kerry Group
Nature’s Bounty
Raisio Group
Archer Daniels Midland
Amway
BASF
DuPont
Fonterra
Kellogg's
Cargill
Conagra
Nestlé
Tate & Lyle
General Mills
Ingredion
Oral Nutraceutical Segment by Type
Oral Solid Dosage Forms
Oral Liquid Dosage Forms
Oral Nutraceutical Segment by Application
Home Use
Hospital Use
Oral Nutraceutical Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Nutraceutical market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oral Nutraceutical and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Nutraceutical.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Oral Nutraceutical companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Oral Solid Dosage Forms
- Oral Liquid Dosage Forms
Applications
- Home Use
- Hospital Use
Companies covered
- DSM
- Barilla Group
- Freedom Food Group Limited
- Glanbia
- Hero Group
- Kerry Group
- Nature’s Bounty
- Raisio Group
- Archer Daniels Midland
- Amway
- BASF
- DuPont
- Fonterra
- Kellogg's
- Cargill
- Conagra
- Nestlé
- Tate & Lyle
- General Mills
- Ingredion
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Oral Nutraceutical by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Oral Solid Dosage Forms
- 2.2.3 Oral Liquid Dosage Forms
- 2.3 Oral Nutraceutical by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Home Use
- 2.3.3 Hospital Use
- 2.4 Assumptions and Limitations
3 Oral Nutraceutical Breakdown Data by Type
- 3.1 Global Oral Nutraceutical Historic Market Size by Type (2021-2026)
- 3.2 Global Oral Nutraceutical Forecasted Market Size by Type (2027-2032)
4 Oral Nutraceutical Breakdown Data by Application
- 4.1 Global Oral Nutraceutical Historic Market Size by Application (2021-2026)
- 4.2 Global Oral Nutraceutical Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Oral Nutraceutical Market Perspective (2021-2032)
- 5.2 Global Oral Nutraceutical Growth Trends by Region
- 5.2.1 Global Oral Nutraceutical Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Oral Nutraceutical Historic Market Size by Region (2021-2026)
- 5.2.3 Oral Nutraceutical Forecasted Market Size by Region (2027-2032)
- 5.3 Oral Nutraceutical Market Dynamics
- 5.3.1 Oral Nutraceutical Industry Trends
- 5.3.2 Oral Nutraceutical Market Drivers
- 5.3.3 Oral Nutraceutical Market Challenges
- 5.3.4 Oral Nutraceutical Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Oral Nutraceutical Players by Revenue
- 6.1.1 Global Top Oral Nutraceutical Players by Revenue (2021-2026)
- 6.1.2 Global Oral Nutraceutical Revenue Market Share by Players (2021-2026)
- 6.2 Global Oral Nutraceutical Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Oral Nutraceutical Head Office and Area Served
- 6.4 Global Oral Nutraceutical Players, Product Type & Application
- 6.5 Global Oral Nutraceutical Manufacturers Established Date
- 6.6 Global Oral Nutraceutical Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Oral Nutraceutical Market Size (2021-2032)
- 7.2 North America Oral Nutraceutical Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Oral Nutraceutical Market Size by Country (2021-2026)
- 7.4 North America Oral Nutraceutical Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Oral Nutraceutical Market Size (2021-2032)
- 8.2 Europe Oral Nutraceutical Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Oral Nutraceutical Market Size by Country (2021-2026)
- 8.4 Europe Oral Nutraceutical Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Oral Nutraceutical Market Size (2021-2032)
- 9.2 Asia-Pacific Oral Nutraceutical Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Oral Nutraceutical Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Oral Nutraceutical Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Oral Nutraceutical Market Size (2021-2032)
- 10.2 South America Oral Nutraceutical Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Oral Nutraceutical Market Size by Country (2021-2026)
- 10.4 South America Oral Nutraceutical Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Oral Nutraceutical Market Size (2021-2032)
- 11.2 Middle East & Africa Oral Nutraceutical Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Oral Nutraceutical Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Oral Nutraceutical Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 DSM
- 12.1.1 DSM Company Information
- 12.1.2 DSM Business Overview
- 12.1.3 DSM Revenue in Oral Nutraceutical Business (2021-2026)
- 12.1.4 DSM Oral Nutraceutical Product Portfolio
- 12.1.5 DSM Recent Developments
- 12.2 Barilla Group
- 12.2.1 Barilla Group Company Information
- 12.2.2 Barilla Group Business Overview
- 12.2.3 Barilla Group Revenue in Oral Nutraceutical Business (2021-2026)
- 12.2.4 Barilla Group Oral Nutraceutical Product Portfolio
- 12.2.5 Barilla Group Recent Developments
- 12.3 Freedom Food Group Limited
- 12.3.1 Freedom Food Group Limited Company Information
- 12.3.2 Freedom Food Group Limited Business Overview
- 12.3.3 Freedom Food Group Limited Revenue in Oral Nutraceutical Business (2021-2026)
- 12.3.4 Freedom Food Group Limited Oral Nutraceutical Product Portfolio
- 12.3.5 Freedom Food Group Limited Recent Developments
- 12.4 Glanbia
- 12.4.1 Glanbia Company Information
- 12.4.2 Glanbia Business Overview
- 12.4.3 Glanbia Revenue in Oral Nutraceutical Business (2021-2026)
- 12.4.4 Glanbia Oral Nutraceutical Product Portfolio
- 12.4.5 Glanbia Recent Developments
- 12.5 Hero Group
- 12.5.1 Hero Group Company Information
- 12.5.2 Hero Group Business Overview
- 12.5.3 Hero Group Revenue in Oral Nutraceutical Business (2021-2026)
- 12.5.4 Hero Group Oral Nutraceutical Product Portfolio
- 12.5.5 Hero Group Recent Developments
- 12.6 Kerry Group
- 12.6.1 Kerry Group Company Information
- 12.6.2 Kerry Group Business Overview
- 12.6.3 Kerry Group Revenue in Oral Nutraceutical Business (2021-2026)
- 12.6.4 Kerry Group Oral Nutraceutical Product Portfolio
- 12.6.5 Kerry Group Recent Developments
- 12.7 Nature’s Bounty
- 12.7.1 Nature’s Bounty Company Information
- 12.7.2 Nature’s Bounty Business Overview
- 12.7.3 Nature’s Bounty Revenue in Oral Nutraceutical Business (2021-2026)
- 12.7.4 Nature’s Bounty Oral Nutraceutical Product Portfolio
- 12.7.5 Nature’s Bounty Recent Developments
- 12.8 Raisio Group
- 12.8.1 Raisio Group Company Information
- 12.8.2 Raisio Group Business Overview
- 12.8.3 Raisio Group Revenue in Oral Nutraceutical Business (2021-2026)
- 12.8.4 Raisio Group Oral Nutraceutical Product Portfolio
- 12.8.5 Raisio Group Recent Developments
- 12.9 Archer Daniels Midland
- 12.9.1 Archer Daniels Midland Company Information
- 12.9.2 Archer Daniels Midland Business Overview
- 12.9.3 Archer Daniels Midland Revenue in Oral Nutraceutical Business (2021-2026)
- 12.9.4 Archer Daniels Midland Oral Nutraceutical Product Portfolio
- 12.9.5 Archer Daniels Midland Recent Developments
- 12.10 Amway
- 12.10.1 Amway Company Information
- 12.10.2 Amway Business Overview
- 12.10.3 Amway Revenue in Oral Nutraceutical Business (2021-2026)
- 12.10.4 Amway Oral Nutraceutical Product Portfolio
- 12.10.5 Amway Recent Developments
- 12.11 BASF
- 12.11.1 BASF Company Information
- 12.11.2 BASF Business Overview
- 12.11.3 BASF Revenue in Oral Nutraceutical Business (2021-2026)
- 12.11.4 BASF Oral Nutraceutical Product Portfolio
- 12.11.5 BASF Recent Developments
- 12.12 DuPont
- 12.12.1 DuPont Company Information
- 12.12.2 DuPont Business Overview
- 12.12.3 DuPont Revenue in Oral Nutraceutical Business (2021-2026)
- 12.12.4 DuPont Oral Nutraceutical Product Portfolio
- 12.12.5 DuPont Recent Developments
- 12.13 Fonterra
- 12.13.1 Fonterra Company Information
- 12.13.2 Fonterra Business Overview
- 12.13.3 Fonterra Revenue in Oral Nutraceutical Business (2021-2026)
- 12.13.4 Fonterra Oral Nutraceutical Product Portfolio
- 12.13.5 Fonterra Recent Developments
- 12.14 Kellogg's
- 12.14.1 Kellogg's Company Information
- 12.14.2 Kellogg's Business Overview
- 12.14.3 Kellogg's Revenue in Oral Nutraceutical Business (2021-2026)
- 12.14.4 Kellogg's Oral Nutraceutical Product Portfolio
- 12.14.5 Kellogg's Recent Developments
- 12.15 Cargill
- 12.15.1 Cargill Company Information
- 12.15.2 Cargill Business Overview
- 12.15.3 Cargill Revenue in Oral Nutraceutical Business (2021-2026)
- 12.15.4 Cargill Oral Nutraceutical Product Portfolio
- 12.15.5 Cargill Recent Developments
- 12.16 Conagra
- 12.16.1 Conagra Company Information
- 12.16.2 Conagra Business Overview
- 12.16.3 Conagra Revenue in Oral Nutraceutical Business (2021-2026)
- 12.16.4 Conagra Oral Nutraceutical Product Portfolio
- 12.16.5 Conagra Recent Developments
- 12.17 Nestlé
- 12.17.1 Nestlé Company Information
- 12.17.2 Nestlé Business Overview
- 12.17.3 Nestlé Revenue in Oral Nutraceutical Business (2021-2026)
- 12.17.4 Nestlé Oral Nutraceutical Product Portfolio
- 12.17.5 Nestlé Recent Developments
- 12.18 Tate & Lyle
- 12.18.1 Tate & Lyle Company Information
- 12.18.2 Tate & Lyle Business Overview
- 12.18.3 Tate & Lyle Revenue in Oral Nutraceutical Business (2021-2026)
- 12.18.4 Tate & Lyle Oral Nutraceutical Product Portfolio
- 12.18.5 Tate & Lyle Recent Developments
- 12.19 General Mills
- 12.19.1 General Mills Company Information
- 12.19.2 General Mills Business Overview
- 12.19.3 General Mills Revenue in Oral Nutraceutical Business (2021-2026)
- 12.19.4 General Mills Oral Nutraceutical Product Portfolio
- 12.19.5 General Mills Recent Developments
- 12.20 Ingredion
- 12.20.1 Ingredion Company Information
- 12.20.2 Ingredion Business Overview
- 12.20.3 Ingredion Revenue in Oral Nutraceutical Business (2021-2026)
- 12.20.4 Ingredion Oral Nutraceutical Product Portfolio
- 12.20.5 Ingredion Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst